HPLC, UHPLC
LC-MS links amino acids with lung cancer
Dec 23 2010
Scientists in Japan write in BMC Cancer of how LC-MS was used to measure amino acid concentrations in blood samples obtained from a control group and from NSCLC patients awaiting treatment.
After identifying difference in the amino acids expressed in the blood of each group, the scientists looked to whether the discrepancies were consistent.
They found that, regardless of histology or progression of the disease, amino acids can allow NSCLC patients to be distinguished from control individuals.
"The amino acid balance in cancer patients often differs from that in healthy individuals because of metabolic changes," the scientists explain in their paper.
BMC Cancer is a peer-reviewed periodical specialising in pathophysiology, diagnosis, treatment and prevention of cancer.
Digital Edition
Chromatography Today - Buyers' Guide 2022
October 2023
In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Sep 04 2024 Chiba, Tokyo, Japan